According to NICE guidance (NG28), these medications have demonstrated significant benefits in glycaemic control, with some specific agents (semaglutide, liraglutide, dulaglutide) also showing cardiovascular risk reduction in clinical trials
Start your intake Clinical trials of semaglutide for weight loss documented nausea, vomiting, diarrhea, and constipation as the most frequent side effects, but sore throat did not appear as a primary adverse event
Those concerns sit alongside the standard risks including rare pancreatitis
These elements are crucial as they can transcribe the expression of MTs, particularly by minimizing ROS-mediated cytotoxicity, thus adding another layer of protection against arsenics harmful effects
Neurodegenerative diseases often disrupt neuromodulatory pathways, further impairing cognitive and motor functions